Skip to main content

Table 2 Univariable and multivariable analyses of potential predictors of colonization with multiple species of extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE)-comparison of case group 1a and control group 3a

From: Risk factors for colonization with multiple species of extended-spectrum beta-lactamase producing Enterobacterales: a case-case–control study

 

Univariable analyses

Multivariable analysesb

OR

95%CI

p-value

OR

95%CI

p-value

Age

0.99

0.97–1.01

0.204

   

Female sex

0.89

0.45–1.75

0.730

   

Admission from nursing-home / long-term healthcare

1.23

0.32–4.80

0.766

   

Admission from other acute care facility

2.37

0.84–6.67

0.103

   

Recent hospitalizationc

1.50

0.71–3.13

0.291

   

Recent ICU stayc

1.45

0.59–3.56

0.413

   

Travelc

12.3

3.49–43.37

< 0.001

12.57

3.48–45.45

< 0.001

Hospitalization abroadc

23.51

3.03–182.21

0.003

   

Charlson Comorbidity Index

0.96

0.81–1.14

0.632

   

Solid organ transplantation

0.76

0.20–2.97

0.695

   

Urinary catheterizationd

0.74

0.32–1.69

0.470

   

Vascular hardwaree

2

0.35–11.31

0.433

   

Recent surgeryf

0.89

0.43–1.85

0.759

   

Active open woundsg

0.70

0.23–2.14

0.533

   

Prior antibiotic therapyh

2.88

1.42–5.84

0.003

2.96

1.37–6.41

0.006

Immunosuppressive therapyc

0.96

0.45–2.04

0.912

   

Proton-pump inhibitor therapyh

1.19

0.60–2.38

0.616

   
  1. Bold represents statistically significant (p-values ≤ 0.05)
  2. aGroup 1 = patients with multiple species of ESBL-PE within one hospitalization, Group 3 = control patients with colonization of one species of ESBL-PE within different hospitalizations
  3. bMultivariable analyses included the variables travel, hospitalization abroad, prior antibiotic therapy. Only variables identified by stepwise logistic regression using stepwise forward and backward selection as well as Akaike information criterion are presented in the table
  4. cWithin the past 12 months
  5. dTransurethral or suprapubic within 30 days prior to index sample
  6. eIn place for at least 7 days prior to index sample
  7. fWithin the past 6 months
  8. gDiabetic ulcers, decubitus ulcers, or other draining wounds
  9. hWithin 3 months prior to index sample